Nephrology

FDA: NSAID Use Should Be Avoided in Pregnancy Even Sooner Than 30 Weeks

Publish Date October 21, 2020

The use of NSAIDs after 20 weeks of pregnancy may lead to low levels of amniotic fluid surrounding the baby resulting in kidney complications.

Hospital Outcomes Worse for Children With Chronic Kidney Disease

Publish Date October 15, 2020

Length of stay, costs, mortality risk greater than for children hospitalized with other chronic illnesses.

Risk of Nonspinal Fracture Increased in Moderate to Severe CKD

Publish Date October 13, 2020

Fracture prevention efforts should be considered in patients with CKD of any age, according to investigators.

Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication

Publish Date October 7, 2020

The designation was granted based on results from the phase 3 DAPA-CKD trial, which was stopped early due to “overwhelming efficacy”.

Fruits, Vegetables May Offer Edge in Correcting Metabolic Acidosis in CKD

Publish Date October 5, 2020

Increased intake of fruits and vegetables corrects CKD-related metabolic acidosis as well as sodium bicarbonate supplements, but is associated with other health benefits, a new post hoc analysis found.

Prescription Analgesic Use High in the Elderly CKD Population

Publish Date October 1, 2020

Older patients with CKD may be especially at risk for suboptimal pain control and inappropriate use of opioids and prescription NSAIDs, according to study investigators.

SARS-CoV-2 Seroprevalence Low Among US Dialysis Patients

Publish Date September 28, 2020

Study findings suggest that COVID-19 control efforts should prioritize ethnic minorities and patients living in densely populated areas to prevent spread.

Antidepressant, NSAID Identified as Culprits in SIADH Case

Publish Date September 25, 2020

The patient noted that she was initiated on naproxen by her primary care physician 2 weeks prior to her presentation.

Death More Common Than Kidney Failure Among Older Patients With Severe CKD

Publish Date September 22, 2020

The risk of death is much higher than that of kidney failure among patients with stage 4 chronic kidney disease who are aged 75 years or older.

FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1

Publish Date September 17, 2020

In July 2020, the FDA Cardiovascular and Renal Drugs Advisory Committee narrowly voted 8 to 7 in favor of the approval of terlipressin for HRS-1.